A comparative scientific review of tirzepatide and semaglutide, examining receptor pharmacology, dual GIP/GLP-1 agonism versus selective GLP-1 activation,
Read more Tirzepatide vs. Semaglutide: Comparative Pharmacology and Research Evidence
This comparative review examines retatrutide and tirzepatide, evaluating how retatrutide’s triple-receptor agonism (GLP-1, GIP, and glucagon) differs mecha
Read more Retatrutide vs. Tirzepatide: How Triple Agonism Compares to Dual Agonism
While approved for diabetes and weight management, tirzepatide is under active investigation for broader cardiometabolic indications. Emerging clinical tri
Read more Tirzepatide in Emerging Indications: Liver, Kidney, and Cardiovascular Research
A comprehensive review of the clinical evidence for tirzepatide, examining glycemic and weight loss outcomes across the landmark SURPASS and SURMOUNT phase
Read more Tirzepatide Clinical Evidence: What the SURPASS and SURMOUNT Trials Show
A structured Minto Pyramid review examining tirzepatide’s pharmacology, evidence hierarchy, and dual GIP/GLP-1 receptor agonism in metabolic and endocrine